glp 1 agonist ppt GLP-1 The Evolution and Impact of
Description
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents
Across the dataset, a few patterns stood out: Zepboundposts mention fatigue, constipation, and hair thinning more than any other drug
CMS GLP-1 Bridge Program: Medicare Part D coverage for weight-loss GLP-1 drugs starting July 1, 2026, including eligibility, covered medications, prior authorization, and copay rules.
Case reports document perioperative aspiration in semaglutide users, including episodes of hypoxemia and reintubation despite guideline-concordant fasting
GLP-1 receptor agonists, such as Ozempic (semaglutide), have gained significant attention in recent years for their impressive weight loss results
